Technical analysis of United Therapeutics Corporation (UTHR): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
United Therapeutics Corporation, a biotechnology firm, is dedicated to discovering, developing, and bringing to market medical solutions for individuals suffering from chronic and severe, often life-threatening, illnesses. Its operations span both the United States and international markets.
Price Performance
| 1 month | +9.53% |
| 3 months | +14.65% |
| Year-to-date | +21.81% |
| 1 year | +30.87% |
| 3 years | +166.33% |
| 5 years | +211.14% |
| 10 years | +395.07% |
52-Week Range
| 52-week High | $609.35 |
| 52-week Low | $415.26 |
| Avg Volume (90d) | 613K |
Technical Indicators
| SMA 50 | $525.55 |
| SMA 200 | $530.92 |
| Beta | 0.75 |
| 30-day Volatility (annualised) | 46.4% |
| Price vs SMA 50 | +12.9% |
| Price vs SMA 200 | +11.8% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-12 | $487.25 | |
| 2026-01 | $469.49 | -3.6% |
| 2026-02 | $503.90 | +7.3% |
| 2026-03 | $592.98 | +17.7% |
| 2026-04 | $571.35 | -3.6% |
| 2026-05 | $556.82 | -2.5% |
| 2026-06 | $541.83 | -2.7% |
| 2026-07 | $517.71 | -4.5% |
| 2026-08 | $510.38 | -1.4% |
| 2026-08 | $510.38 | +0.0% |
| 2026-09 | $541.89 | +6.2% |
| 2026-10 | $593.54 | +9.5% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-11-04 | $6.01 | $781M |
| 2026-08-05 | $6.86 | $805M |
| 2026-05-06 | $7.00 | $797M |
| 2026-02-25 | $7.13 | $813M |
| 2025-10-29 | $6.89 | $815M |
| 2025-07-30 | $7.29 | $802M |
| 2025-04-30 | $6.29 | $779M |
Price
| Price | $582.47 (closing price, October 29, 2026) |
| Market Cap | $25.0B |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| P/E Ratio | 20.87 |
| Price / Book | 3.95 |
| EV / EBITDA | 14.11 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.00 |
| Current Ratio | 5.73 |
| Piotroski F-Score | 7 |
| Altman Z-Score | 19.56 |